LAURA OZIMKOVSKI: Open Payments
NPI 1821205303 · JACKSONVILLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$192 in 4 payments from 3 companies in 2025. Trend: 2023 $280 · 2024 $187 · 2025 $192
Food & beverage: $192
| Company | Payments | Amount |
|---|---|---|
| Xeris Pharmaceuticals, Inc. | 1 | $125 |
| Novo Nordisk Inc | 2 | $51 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $16 |
Products named: GVOKE HYPOPEN, Rybelsus, Ozempic, Kerendia.
Industry payments across FL — which companies pay providers there.
